Respiratory Medicine
Volume 106, Issue 4 , Pages 531-539 , April 2012

AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD

  • Piotr Kuna

      Affiliations

    • Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland
    • Corresponding Author InformationCorresponding author. Tel.: +48 (42) 6776777; fax: +48 (42) 6781176.
    • ,
  • Martin Jenkins

      Affiliations

    • Statistics and Informatics, AstraZeneca, Alderley Park, UK
    • ,
  • Christopher D. O’Brien

      Affiliations

    • Respiratory/Inflammation, AstraZeneca, Wilmington, DE, USA
    • ,
  • William A. Fahy

      Affiliations

    • Respiratory/Inflammation, AstraZeneca, Charnwood, UK

Received 10 August 2011 ,Accepted 31 October 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(11)00384-2

doi: 10.1016/j.rmed.2011.10.020

Respiratory Medicine
Volume 106, Issue 4 , Pages 531-539 , April 2012

Article Tools

* Image Usage & Resolution